REOGLYUMAN (Rheoglumanum).

     The drug, which is a 10% dextran solution with molecular mass 40000 # 10000 with the addition of 5% mannitol and 0.9% sodium chloride in water for injection.

     Transparent colourless and odourless liquid; PH 4, 6-0, 5; The relative strength at temperatures + 25 'C is not more than 7, 0.

     The drug is seen as practically blood products : it reduces the viscosity of the blood, helps restore blood flow in small capillaries, reduces aggregation identifications of blood has dezintoksikatsionnoe, osmodiurticheskoe and gemodinamicheskoe effect.

     Reoglyuman applied to improve capillary blood diseases involving violations of microcirculation and delayed fluid in the body, including trauma, operating, kardiogennom, Burns shock, in breach of blood and venous blood flow (brain; Trombophlebitis, endarteriity etc.), for detoxification with burns, peritonitis, pancreatitis, etc.

     Enter reoglyuman intravenous drip. Beginning with the introduction of 5 to 10 drops per minute in 10 - 15 minutes. After a 5 - 10 drops, then 30 drops, making breaks at 2 to 3 minutes; If no undesirable reactions go to a drug at the rate of 40 drops per minute.

     Dose and speed of selecting individually depending on the testimony of the patient, diureza.

     To maintain electrolyte balance to be with reoglyumanom solutions containing sodium and potassium. In a shock therapy to introduce usually between 400 and 800 ml in a 30 reoglyumana 60 minutes (controlled hemodynamic performance and diureza).

     In cardiac surgery impose 30-60 min before surgery to 10 ml / kg reoglyumana during operations 400-500 ml, and after each day operation of the 5 - 6 days drip at the rate of 10 ml / kg.

     In acute liver failure Renal (saved from filtering ability) to impose one on the 400-800 ml; Then daily (for 3 - 5 day) apply at the rate of 10 ml / kg to introduce, under the control of the water electrolyte and acid core of , and blood coagulation.

     Possible complications, precautions and contraindications such as when applying poliglyukina. Do not apply excessive reoglyuman with gemodilyutsii (Hematocrit below 25 pc) And with haemorrhagic diathesis (thrombocytopenia).

     Product : in bottles of 100; 200, and 400 ml.

     Storage : at a temperature of not less than 10 and not more than + 25 C. In transportation possible short-term decline in storage temperature to 10 'C.

Materials allowed to copy only with the active hyperlink to the handbook of medicines